References
- Steptoe PC, Edwards RG. Birth after the reimplantation of a human embryo. Lancet2(8085), 366 (1978).
- Nargund G, Fauser BC, Macklon NS, Ombelet W, Nygren K, Frydman R; Rotterdam ISMAAR Consensus Group on Terminology for Ovarian Stimulation for IVF. The ISMAAR proposal on terminology for ovarian stimulation for IVF. Hum. Reprod.22(11), 2801–2804 (2007).
- Land JA, Yarmolinskaya MI, Dumoulin JC, Evers JL. High-dose human menopausal gonadotropin. Fertil. Steril.65, 961–965 (1996).
- Karande V, Morris R, Rinehart J, Miller C, Rao R, Gleicher N. Limited success using the “flare” protocol in poor responders in cycles with low basal follicle-stimulating hormone levels during in vitro fertilization. Fertil. Steril.67(5), 900–903 (1997).
- Moreno C, Ruiz A, Simon C, Pellicer A, Remohi J. Intracytoplasmic sperm injection as a routine indication in low responder patients. Hum. Reprod.13(8), 2126–2129 (1998).
- Keay SD, Lenton EA, Cooke ID, Hull MG, Jenkins JM. Low-dose dexamethasone augments the ovarian response to exogenous gonadotrophins leading to a reduction in cycle cancellation rate in a standard IVF programme. Hum. Reprod.16(9), 1861–1865 (2001).
- Mitwally MF, Casper RF. Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders. Fertil. Steril.77(4), 776–780 (2002).
- Lok IH, Yip SK, Cheung LP et al. Adjuvant low-dose aspirin therapy in poor responders undergoing in vitro fertilization: a prospective, randomized, double-blind, placebo-controlled trial. Fertil. Steril.81(3), 556–561 (2004).
- Rongières-Bertrand C, Olivennes F, Righini C, et al. Revival of the natural cycles in in vitro fertilization with the use of a new gonadotrophin-releasing hormone antagonist (Cetrorelix): a pilot study with minimal stimulation. Hum. Reprod.14(3), 683–688 (1999).
- Daya S, Gunby J, Hughes EG, Collins JA, Sagle MA, YoungLai EV. Natural cycles for in vitro fertilization: cost–effectiveness analysis and factors influencing outcome. Hum. Reprod.10(7), 1719–1724 (1995).
- Mendez Lozano DH, Fanchin R, Chevalier N et al. The follicular flushing duplicate the pregnancy rate on semi natural cycle IVF. J. Gynecol. Obstet. Biol. Reprod. (Paris)36(1), 36–41 (2007).
- Bassil S, Godin PA, Donnez J. Outcome of in vitro fertilization through natural cycles in poor responders. Hum. Reprod.14(5), 1262–1265 (1999).
- Janssens RM, Lambalk CB, Vermeiden JP, Schats R, Schoemaker J. In vitro fertilization in a spontaneous cycle: easy, cheap and realistic. Hum. Reprod.15(2), 314–318 (2000).
- Ubaldi FM, Rienzi L, Ferrero S et al. Management of poor responders in IVF. Reprod. Biomed. Online10(2), 235–246 (2005).
- Castelo Branco A, Achour-Frydman N, Kadoch J, Fanchin R, Tachdjian G, Frydman R. In vitro fertilization and embryo transfer in seminatural cycles for patients with ovarian aging. Fertil. Steril.84(4), 875–880 (2005).
- Pelinck MJ, Hoek A, Simons AH, Heineman MJ. Efficacy of natural cycle IVF: a review of the literature. Hum. Reprod. Update8(2), 129–139 (2002).
- Nargund G, Waterstone J, Bland J, Philips Z, Parsons J, Campbell S. Cumulative conception and live birth rates in natural (unstimulated) IVF cycles. Hum. Reprod.16(2), 259–262 (2001).
- Morgia F, Sbracia M, Schimberni M et al. A controlled trial of natural cycle versus microdose gonadotropin-releasing hormone analog flare cycles in poor responders undergoing in vitro fertilization. Fertil. Steril.81(6), 1542–1547 (2004).
- Fauser BC, Devroey P, Yen SS, Gosden R, Crowley WF Jr, Baird DT. Minimal ovarian stimulation for IVF: appraisal of potential benefit and drawbacks. Hum. Reprod.14, 2681–2686 (1999).
- Baart EB, Martini E, Eijkemans MJ et al. Milder ovarian stimulation for in vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial. Hum. Reprod.22(4), 980–988 (2007).
- Ziebe S, Bangsboll S, Schmidt KL, Loft A, Lindhard A, Nyboe Andersen A. Embryo quality in natural versus stimulated IVF cycles. Hum. Reprod.19(6), 1457–1460 (2004).
- Basir GS, O WS, Ng EH, Ho PC. Morphometric analysis of peri-implantation endometrium in patients having excessively high oestradiol concentrations after ovarian stimulation. Hum. Reprod.16(3), 435–440 (2001).
- Devroey P, Bourgain C, Macklon NS, Fauser BC. Reproductive biology and IVF: ovarian stimulation and endometrial receptivity. Trends Endocrinol. Metab.15(2), 84–90 (2004).
- Kolb BA, Paulson RJ. The luteal phase of cycles utilizing controlled ovarian hyperstimulation and the possible impact of this hyperstimulation on embryo implantation. Am. J. Obstet. Gynecol.176(6), 1262–1267 (1997).
- Macklon NS, Fauser BC. Impact of ovarian hyperstimulation on the luteal phase. J. Reprod. Fertil. Suppl.55, 101–108 (2000).
- Tavaniotou A, Albano C, Smitz J, Devroey P. Impact of ovarian stimulation on corpus luteum function and embryonic implantation. J. Reprod. Immunol.55(1–2), 123–130 (2002).
- Horcajadas JA, Riesewijk A, Polman J et al. Effect of controlled ovarian hyperstimulation in IVF on endometrial gene expression profiles. Mol. Hum. Reprod.11(3), 195–205 (2005).
- Oehninger S. Revealing the enigmas of implantation: what is the true impact of ovarian hyperstimulation? Fertil. Steril.89(1), 27–30 (2008).
- Martínez-Conejero JA, Simón C, Pellicer A, Horcajadas JA. Is ovarian stimulation detrimental to the endometrium. Reprod. Biomed. Online15(1), 45–50 (2007).
- Lédée-Bataille N, Dubanchet S, Kadoch J, Castelo-Branco A, Frydman R, Chaouat G. Controlled natural in vitro fertilization may be an alternative for patients with repeated unexplained implantation failure and a high uterine natural killer cell count. Fertil. Steril.82(1), 234–236 (2004).
- Lukassen HG, Joosten I, van Cranenbroek B et al. Hormonal stimulation for IVF treatment positively affects the CD56bright/CD56dim NK cell ratio of the endometrium during the window of implantation. Mol. Hum. Reprod.10(7), 513–520 (2004).
- Pelinck MJ, Vogel NE, Hoek A et al. Cumulative pregnancy rates after three cycles of minimal stimulation IVF and results according to subfertility diagnosis: a multicentre cohort study. Hum. Reprod.21(9), 2375–2383 (2006).
- Duckitt K, Templeton AA. Cancer in women with infertility. Curr. Opin. Obstet. Gynecol.10(3), 199–203 (1998).
- Lee SJ, Schover LR, Partridge AH et al., American Society of Clinical Oncology. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J. Clin. Oncol.24(18), 2917–2931 (2006).
- Delvigne A, Rozenberg S. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum. Reprod. Update8(6), 559–577 (2002).
- Chan WS, Dixon ME. The “ART” of thromboembolism: a review of assisted reproductive technology and thromboembolic complications. Thromb. Res.121(6), 713–726 (2008).
- Magnani B, Tsen L, Datta S, Bader A. In vitro fertilization. Do short-term changes in estrogen levels produce increased fibrinolysis? Am. J. Clin. Pathol.112(4), 485–491 (1999).
- Aurousseau MH, Samama MM, Belhassen A, Herve F, Hugues JN. Risk of thromboembolism in relation to an in vitro fertilization programme: three case reports. Hum. Reprod.10(1), 94–97 (1995).
- Curvers J, Nienhuis SJ, Nap AW, Hamulyák K, Evers JL, Rosing J. Activated protein C resistance during in vitro fertilization treatment. Eur. J. Obstet. Gynecol. Reprod. Biol.95(2), 222–224 (2001).
- Yinon Y, Pauzner R, Dulitzky M, Elizur SE, Dor J, Shulman A. Safety of IVF under anticoagulant therapy in patients at risk for thrombo-embolic events. Reprod. Biomed. Online12(3), 354–358 (2006).
- Ombelet W, Campo R. Affordable IVF for developing countries. Reprod. Biomed. Online15(3), 257–265 (2007).
- Heijnen EM, Eijkemans MJ, De Klerk C et al. A mild treatment strategy for in vitro fertilisation: a randomised non-inferiority trial. Lancet369(9563), 743–749 (2007).